References
- Wells KB, Stewart A, Hays RD, Burnam MA, Rogers WH, Hays RD, et al. The functioning and well-being of depressed patients: Results from the Medical Outcomes Study. JAMA 1989; 262: 914–9
- Evans DL, Charney DS, Lewis L, Golden RN, Gorman JM, Krishnan KR, et al. Mood disorders in the medically ill: Scientific review and recommendations. Biol Psychiatry 2005; 58: 175–89
- Verhaak PF, Heijmans MJ, Peters L, Rijken M. Chronic disease and mental disorder. Soc Sci Med 2005; 60: 789–97
- Wulsin LR, Vaillant GE, Wells VE. A systematic review of the mortality of depression. Psychosom Med 1999; 61: 18–20
- Eckel RH, Grundy SM, Zimmet PZ. The metabolic syndrome. Lancet 2005; 365: 1415–28
- Laaksonen DE, Lakka HM, Niskanen LK, Kaplan GA, Salonen JT, Lakka TA. Metabolic syndrome and development of diabetes mellitus: Application and validation of recently suggested definitions of the metabolic syndrome in a prospective cohort study. Am J Epidemiol 2002; 156: 1070–7
- Facchini FS, Hua N, Abbasi F, Reaven GM. Insulin resistance as a predictor of age-related diseases. J Clin Endocrinol Metab 2001; 86: 3574–8
- Guize, L, Thomas, F, Pannier, B, Bean, K, Danchin, N, Benetos, A. Metabolic syndrome: Prevalence, risk factors and mortality in a French population of 62000 subjects. Bull Acad Natl Med 2006;190:685–97, (abstract in English).
- Herva A, Rasanen P, Miettunen J, Timonen M, Laksy K, Veijola J, et al. Co-occurrence of metabolic syndrome with depression and anxiety in young adults: The Northern Finland 1966 Birth Cohort Study. Psychosom Med 2006; 68: 213–16
- Timonen M, Laakso M, Jokelainen J, Rajala U, Meyer-Rochow VB, Keinanen-Kiukaanniemi S. Insulin resistance and depression: Cross sectional study. BMJ 2005; 330: 17–18
- Schlotz W, Ambery P, Syddall HE, Crozier SR, Sayer AA, Cooper C, Phillips DI. The Hertfordshire Cohort Study Group. Specific associations of insulin resistance with impaired health-related quality of life in the Hertfordshire Cohort Study. Qual Life Res 2007; 16: 429–36
- Kinder LS, Carnethon MR, Palaniappan LP, King AC, Fortmann SP. Depression and the metabolic syndrome in young adults: Findings from the Third National Health and Nutrition Examination Survey. Psychosom Med 2004; 66: 316–22
- Räikkonen K, Matthews KA, Kuller LH. The relationship between psychological risk attributes and the metabolic syndrome in healthy women: Antecedent or consequence?. Metabolism 2002; 51: 1573–7
- Räikkönen K, Matthews KA, Kuller LH. Depressive symptoms and stressful life events predict metabolic syndrome among middle-aged women: A comparison of World Health Organization, Adult Treatment Panel III, and International Diabetes Foundation definitions. Diabetes Care 2007; 30: 872–7
- Engum A. The role of depression and anxiety in onset of diabetes in a large population-based study. J Psychosom Res 2007; 62: 31–8
- Heiskanen TH, Niskanen LK, Hintikka JJ, Koivumaa-Honkanen HT, Honkalampi KM, Haatainen KM, et al. Metabolic syndrome and depression: A cross-sectional analysis. J Clin Psychiatry 2006; 67: 1422–7
- Beck AT, Ward CH, Mendelson M, Mock J, Erbaugh J. An inventory for measuring depression. Arch Gen Psychiatry 1961; 4: 561–71
- Viinamäki H, Tanskanen A, Honkalampi K, Koivumaa-Honkanen H, Haatainen K, Kaustio O, et al. Is the Beck Depression Inventory suitable for screening major depression in different phases of the disease?. Nord J Psychiatry 2004; 58: 49–53
- Grundy SM, Cleeman JI, Daniels SR, Donato KA, Eckel RH, Franklin BA, et al. Diagnosis and management of the metabolic syndrome: An American Hearth Association/National Heart, Lung, and Blood Institute Scientific Statement. Circulation 2005; 112: 2735–52
- Ford ES. Prevalence of the metabolic syndrome defined by the International Diabetes Federation among adults in the US. Diabetes Care 2005; 28: 2745–9
- Ilanne-Parikka P, Eriksson JG, Lindstrom J, Hamalainen H, Keinanen-Kiukaanniemi S, Laakso M, et al. Finnish Diabetes Prevention Study Group. Prevalence of the metabolic syndrome and its components: Findings from a Finnish general population sample and the Diabetes Prevention Study cohort. Diabetes Care 2004; 27: 2135–40
- Troxel WM, Matthews KA, Gallo LC, Kuller LH. Marital quality and occurrence of the metabolic syndrome in women. Arch Intern Med 2005; 165: 1022–7
- Gans RO. The metabolic syndrome, depression, and cardiovascular disease: Interrelated conditions that share pathophysiological mechanisms. Med Clin North Am 2006; 90: 573–91
- Vgontzas AN, Bixler EO, Chrousos GP. Obesity-related sleepiness and fatigue: The role of the stress systems and cytokines. Ann N Y Acad Sci 2006; 1083: 329–44
- Lim W, Hong S, Nelesen R, Dimsdale JE. The association of obesity, cytokine levels, and depressive symptoms with diverse measures of fatigue in healthy subjects. Arch Intern Med 2005; 165: 910–5
- Larsson U, Karlsson J, Sullivan M. Impact of overweight and obesity on health-related quality of life: A Swedish population study. Int J Obes Relat Metab Disord 2002; 26: 417–24
- Esposito K, Giugliano D. Obesity, the metabolic syndrome, and sexual dysfunction. Int J Impot Res 2005; 17: 391–8
- Niskanen L, Laaksonen DE, Punnonen K, Mustajoki P, Kaukua J, Rissanen A. Changes in sex hormone-binding globulin and testosterone during weight loss and weight maintenance in abdominally obese men with the metabolic syndrome. Diabetes Obes Metab 2004; 6: 208–15
- Esposito K, Ciotola M, Marfella R, Di Tommaso D, Cobellis L, Giugliano D. Sexual dysfunction in women with the metabolic syndrome. Diabetes Care 2005; 28: 756
- Korhonen S, Hippelainen M, Vanhala M, Heinonen S, Niskanen L. The androgenic sex hormone profile is an essential feature of metabolic syndrome in premenopausal women: A controlled community-based study. Fertil Steril 2003; 79: 1327–34
- Weber-Hamann B, Werner M, Hentschel F, Bindeballe N, Lederbogen F, Deuschle M, et al. Metabolic changes in elderly patients with major depression: Evidence for increased accumulation of visceral fat at follow-up. Psychoneuroendocrinology 2006; 31: 347–54
- Adriaanse MC, Dekker JM, Spijkerman AM, Twisk JW, Nijpels G, van der Ploeg HM, et al. Diabetes-related symptoms and negative mood in participants of a targeted population-screening program for type 2 diabetes: The Hoorn Screening Study. Qual Life Res 2005; 14: 1501–9
- Earle CM, Stuckey BG. Biochemical screening in the assessment of erectile dysfunction: What tests decide future therapy?. Urology 2003; 62: 727–31